Trials to Begin on Breast Cancer Vaccine

by: cancercompass

Researchers from the University of Arkansas for Medical Sciences expect to start clinical trials this spring on a breast cancer vaccine, reports the Arkansas Democrat-Gazette.

UAMS scientists say they hope to prove the immunotherapy will prevent breast cancer recurrence by tricking the body to produce antibodies that encourage cancer cell death.

According to the newspaper report, patients from Arkansas will participate in the first two phases of the trial, which will include five doses of the vaccine.  If successful, the trials will expand to other cancer centers around the country.

The principal investigator for the clinical trial says the vaccine could become another treatment option for breast cancer patients, if the vaccine proves successful in ongoing clinical trials.